NLRP3 and neoplasm: After NLRP3-specific inhibitor MCC950 was added, the levels of NLRP3, ASC, NOD2 and AIM2 statistically decreased (p < 0.001 and p < 0.0001) upon stimulation with LPS and ATP of tumor cells.